Hormesis can inform future cancer research by encouraging the exploration of novel therapeutic approaches and combinations. For example, combining low-dose radiation with immune checkpoint inhibitors could enhance immune response against tumors. Moreover, understanding hormesis can lead to the development of biomarkers that help identify patients who are likely to benefit from hormesis-based interventions.
